Immune to Cancer: The CRI Blog
-
Dr. Hearn Jay Cho Answers Questions About Blood Cancer And Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Hearn Jay Cho, of Mount Sinai Tisch Cancer Institute, answers questions about blood cancer and immunotherapy…
-
Blood Cancer Awareness Month: 2021 Immunotherapy Research Updates
This September for Blood Cancer Awareness Month, discover new research, treatments, and how CRI is making strides…
-
Blood Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Blood Cancer Awareness Month, we look at how we’re working toward a future immune…
-
How COVID-19 is Impacting Care for Blood Cancer Patients
CRI spoke with Dr. Melody Smith about how clinical care for leukemia, lymphoma, and multiple myeloma patients…
-
Blood Cancer Awareness Month: 2019 Immunotherapy Research Update
For Blood Cancer Awareness Month, we round up the latest news and research from the people changing…
-
ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…
-
Jenny’s Immunotherapy Story
Lymphoma There’s life during cancer, too. Especially when I was doing immunotherapy. Jenny’s Story Jenny was still… -
Jami’s Immunotherapy Story
Lymphoma | Diagnosed 1994 In my history of cancer treatments, I’ve had to be really persistent to stay… -
Second CAR T Cell Immunotherapy Approved for Patients with Lymphoma
A second CAR T cell immunotherapy targeting the CD19 receptor was approved by the FDA for patients…